Hannah Dellabella

Hannah Dellabella

All articles by Hannah Dellabella

news

For patients with rheumatoid arthritis (RA), using conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) concomitantly with biologic DMARDs (bDMARDs) is associated with a significantly reduced risk for bDMARD discontinuation because of adverse events (AEs), according to results published in the Journal of Rheumatology. The study included participants from the Ontario Best Practices Research Initiative (OBRI) who…